Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma

Journal of Acquired Immune Deficiency Syndromes

Volumn 36, Issue 2, 2004, Pages 678-683

  Pyakurel, Pawan ^a   Massambu, Charles ^a,b   Castaños Vélez, Esmeralda ^a,c   Ericsson, Susanna ^a   Kaaya, Ephata ^a,b   Biberfeld, Peter ^a   Heiden, Thomas ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c MetaGen Pharmaceuticals GmbH   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cell proliferation; Human herpesvirus 8; Immunohistochemistry; Kaposi sarcoma; Kaposi sarcoma herpesvirus; Latency associated nuclear antigen

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; KI 67 ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; INFLAMMATORY CELL; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; SPINDLE CELL; TUMOR BIOPSY; VIRUS CELL INTERACTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; KI-67 ANTIGEN; NUCLEAR PROTEINS; SARCOMA, KAPOSI;

EID: 2542420117     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200406010-00004     Document Type: Article

References (34)

1. Amir H, Kaaya EE, Manji KP, et al. Kaposi's sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J. 2001;20:518-521.
2. Ensoli B, Cafaro A. HIV-1 and Kaposi's sarcoma. Eur J Cancer Prev. 1996;5:410-412.
3. Boshoff C, Chang Y. Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med. 2001;52:453-470.
4. Lessan-Pezeshki M, Einollahi B, Khatami MR, et al. Kidney transplantation and Kaposi's sarcoma: review of 2050 recipients. Transplant Proc. 2001;33:2818.
5. Schulz TF. Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res. 1999;76:121-160.
6. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266:1865-1869.
7. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999; 96:4546-4551.
8. Hall KT, Giles MS, Goodwin DJ, et al. Characterization of the herpesvirus saimiri ORF73 gene product. J Gen Virol. 2000;81:2653-2658.
9. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangio-dermatitis). Br J Dermatol. 1996;134:44-46.
10. Olsen SJ, Sarid R, Chang Y, et al. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J Infect Dis. 2000;182:306-310.
11. Renne R, Barry C, Dittmer D, et al. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol. 2001;75:458-468.
12. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-1191.
13. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol. 1997;71:7963-7968.
14. Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 1999;93:4044-4058.
15. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol. 1994;173: 23-31.
16. Uccini S, Sirianni MC, Vincenzi L, et al. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am J Pathol. 1997; 150:929-938.
17. Henry M, Uthman A, Geusau A, et al. Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. J Invest Dermatol. 1999; 113:613-616.
18. Nickoloff BJ. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma. Arch Dermatol. 1991;127:523-529.
19. Russell Jones R, Orchard G, Zelger B, et al. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol. 1995;48:1011-1016.
20. Traweek ST, Kandalaft PL, Mehta P, et al. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol. 1991;96:25-31.
21. Roth WK, Brandstetter H, Sturzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS. 1992;6:895-913.
22. Kaaya EE, Parravicini C, Ordonez C, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10:295-305.
23. Delabesse E, Oksenhendler E, Lebbe C, et al. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol. 1997;50:664-668.
24. Ensoli B, Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998;9:63-83.
25. Hayward GS. Human herpesvirus 8 latent-state gene expression and apoptosis in Kaposi's sarcoma lesions. J Natl Cancer Inst. 1999;91:1705-1707.
26. Judde JG, Lacoste V, Briere J, et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst. 2000;92:729-736.
27. Kaaya E, Castanos-Velez E, Heiden T, et al. Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma. Med Oncol. 2000;17:325-332.
28. Kaaya EE, Parravicini C, Sundelin B, et al. Spindle cell ploidy and proliferation in endemic and epidemic African Kaposi's sarcoma. Eur J Cancer. 1992;11:1890-1894.
29. Simonart T, Degraef C, Noel JC, et al. Overexpression of Bcl-2 in Kaposi's sarcoma-derived cells. J Invest Dermatol. 1998;111:349-353.
30. Sturzl M, Hohenadl C, Zietz C, et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1999;91:1725-1733.
31. Florijn RJ, Slats J, Tanke HJ, et al. Analysis of antifading reagents for fluorescence microscopy. Cytometry. 1995;19:177-182.
32. Sanna PP, Jirikowski GF, Lewandowski GA, et al. Applications of DAPI cytochemistry to neurobiology. Biotech Histochem. 1992;67:346-350.
33. Sturzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer. 1997; 72:68-71.
34. Friborg J Jr, Kong W, Hottiger MO, et al. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 1999;402:889-894.